Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 27;11(2):208-216.
doi: 10.4254/wjh.v11.i2.208.

Central line-associated bloodstream infection among children with biliary atresia listed for liver transplantation

Nicole D Triggs  1 , Stacey Beer  1 , Sonam Mokha  2 , Kat Hosek  3 , Danielle Guffey  4 , Charles G Minard  4 , Flor M Munoz  5 , Ryan W Himes  6
Affiliations

Central line-associated bloodstream infection among children with biliary atresia listed for liver transplantation

Nicole D Triggs et al. World J Hepatol. .

Abstract

Background: Pre-transplant nutrition is a key driver of outcomes following liver transplantation in children. Patients with biliary atresia (BA) may have difficulty achieving satisfactory weight gain with enteral nutrition alone, and parenteral nutrition (PN) may be indicated. While PN has been shown to improve anthropometric parameters of children with BA listed for liver transplantation, less is known about the risks, particularly infectious, associated with this therapy among this specific group of patients.

Aim: To describe the incidence, microbiology, and risk factors of central line-associated bloodstream infection (CLABSI) among children with BA listed for liver transplantation.

Methods: Retrospective review of children aged ≤ 2-years of age with BA who were listed for primary liver transplantation at Texas Children's Hospital from 2008 through 2015 (n = 96). Patients with a central line for administration of PN (n = 63) were identified and details of each CLABSI event were abstracted. We compared the group of patients who experienced CLABSI to the group who did not, to determine whether demographic, clinical, or laboratory factors correlated with development of CLABSI.

Results: Nineteen of 63 patients (30%, 95%CI: 19, 43) experienced 29 episodes of CLABSI during 4800 line days (6.04 CLABSI per 1000 line days). CLABSI was predominantly associated with Gram-negative organisms (14/29 episodes, 48%) including Klebsiella spp., Enterobacter spp., and Escherichia coli. The sole polymicrobial infection grew Enterobacter cloacae and Klebsiella pneumoniae. Gram-positive organisms (all Staphylococcus spp.) and fungus (all Candida spp.) comprised 9/29 (31%) and 6/29 (21%) episodes, respectively. No demographic, clinical, or laboratory factors were significantly associated with an increased risk for the first CLABSI event in Cox proportional hazards regression analysis.

Conclusion: There is substantial risk for CLABSI among children with BA listed for liver transplantation. No clinical, demographic, or laboratory factor we tested emerged as an independent predictor of CLABSI. While our data did not show an impact of CLABSI on the short-term clinical outcome, it would seem prudent to implement CLABSI reduction strategies in this population to the extent that each CLABSI event represents potentially preventable hospitalization, unnecessary healthcare dollar expenditures, and may exact an opportunity cost, in terms of missed allograft offers.

Keywords: Central line-associated bloodstream infection; Central venous catheter; Microbiology; Parenteral nutrition; Pediatric.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All authors declare no conflicts-of-interest related to this article.

Figures

Figure 1
Figure 1
Patient flowchart. BA: Biliary atresia; LT: Liver transplant; CVC: Central venous catheter; PN: Parenteral nutrition; CLABSI: Central line-associated bloodstream infection.
Figure 2
Figure 2
Time to central line-associated bloodstream infection survival analysis. Kaplan-Meier curve of time to CLABSI indicates that 75% of patients remained free of CLABSI on line day 43. CLABSI: Central line-associated bloodstream infection.
Figure 3
Figure 3
Microbiology of central line-associated bloodstream infection events.
See this image and copyright information in PMC

References

    1. Barshes NR, Chang IF, Karpen SJ, Carter BA, Goss JA. Impact of pretransplant growth retardation in pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 2006;43:89–94. - PubMed
    1. Shepherd RW, Chin SE, Cleghorn GJ, Patrick M, Ong TH, Lynch SV, Balderson G, Strong R. Malnutrition in children with chronic liver disease accepted for liver transplantation: clinical profile and effect on outcome. J Paediatr Child Health. 1991;27:295–299. - PubMed
    1. Utterson EC, Shepherd RW, Sokol RJ, Bucuvalas J, Magee JC, McDiarmid SV, Anand R Split Research Group. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr. 2005;147:180–185. - PubMed
    1. DeRusso PA, Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, Schwarz KB, Bezerra JA, Rosenthal P, Karpen S, Squires RH, Magee JC, Robuck PR, Sokol RJ Biliary Atresia Research Consortium. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology. 2007;46:1632–1638. - PMC - PubMed
    1. Sullivan JS, Sundaram SS, Pan Z, Sokol RJ. Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation. Liver Transpl. 2012;18:120–128. - PMC - PubMed